
Why More Pharma Companies Are Turning to Contract Manufacturing in 2025 | by Richard Parkersric | May, 2025 | Medium
Introduction As the pharmaceutical landscape grows increasingly complex, companies are facing tighter regulations, rising R&D costs, and the constant pressure to innovate faster. To navigate these…
https://medium.com/@parkersric/why-more-pharma-companies-are-turning-to-contract-manufacturing-in-2025-2a69dc69852c- Streamlined development of oral solid dose formulations
- Extensive expertise and high-volume manufacturing
- Commitment to quality and regulatory compliance
Our track record speaks volumes
- 17 approved product applications since 2019
- 96% average product yield rate
- Zero critical FDA Form 483 observations
Learn More About Partnering with Lannett.
https://www.lannettcdmo.co...
https://pharmacontractor.b...

Why Tablet Contract Manufacturers Are Key to Scalable Pharmaceutical Growth
In today’s competitive pharmaceutical and nutraceutical industries, bringing a high-quality tablet product to market efficiently and cost-...
https://pharmacontractor.blogspot.com/2025/05/why-tablet-contract-manufacturers-are.htmlhttps://pharmacontractor.b...

Unlocking Growth Through Pharmaceutical Contract Manufacturing Services: The CDMO Advantage
In today’s fast-evolving pharmaceutical landscape, agility, innovation, and compliance are more crucial than ever. For emerging biotechs and...
https://pharmacontractor.blogspot.com/2025/05/unlocking-growth-through-pharmaceutical.htmlhttps://pharmacontractor.e...
https://www.lannettcdmo.co...
https://pharmacontractor.b...

Pharmaceutical Contract Manufacturing: A Growing Industry
The pharmaceutical industry is evolving rapidly, with many companies turning to contract manufacturing organizations (CMOs) to streamline pr...
https://pharmacontractor.blogspot.com/2025/02/pharmaceutical-contract-manufacturing.htmlhttps://pharmaceuticalcont...

The Rise of Biologics and Biosimilars: What It Means for Patients and Pharma – pharmaceutical contract manufacturer
In the ever-evolving digital landscape, subscription-based content has emerged as a powerful model for businesses looking to build long-term relationships with their audiences. From media and entertainment to SaaS and e-learning platforms, companies are leveraging this approach to create consistent ..
https://pharmaceuticalcontractor.wordpress.com/2025/02/06/the-rise-of-biologics-and-biosimilars-what-it-means-for-patients-and-pharma-2/As such, oral solid dose (OSD) formulations are poised to gain significant traction.
This shift demands manufacturing partners with proven expertise in:
💊Specialized potent compound handling
⏳ Modified release technology
🎯 Precise quality control systems
📈 Continuity of supply
https://www.lannettcdmo.co...
Let's discuss more, contact us today!
Our team is committed to providing exceptional support and communication throughout every stage of your project.
Let's discuss more, contact us today!
https://www.lannettcdmo.co...